GigaGen

Giga Gen

Biotechnology, 407 Cabot Rd, San Carlos, California, 94080, United States, 11-50 Employees

gigagen.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 41********

Who is GIGAGEN

GigaGen, a subsidiary of Grifols, is advancing transformative antibody drugs for immune deficiency, infectious diseases and checkpoint resistant cancers by leveraging industry-leading, si...

Read More

map

industries-icon Industry: Biotechnology

SIC SIC Code: 2836 | NAICS Code: 541714 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from GIGAGEN

GigaGen Org Chart and Mapping

Carter Keller

Chief Executive Officer

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding GigaGen

Answer: GigaGen's headquarters are located at 407 Cabot Rd, San Carlos, California, 94080, United States

Answer: GigaGen's phone number is 41********

Answer: GigaGen's official website is https://gigagen.com

Answer: GigaGen's revenue is $1 Million to $5 Million

Answer: GigaGen's SIC: 2836

Answer: GigaGen's NAICS: 541714

Answer: GigaGen has 11-50 employees

Answer: GigaGen is in Biotechnology

Answer: GigaGen contact info: Phone number: 41******** Website: https://gigagen.com

Answer: GigaGen, a subsidiary of Grifols, is advancing transformative antibody drugs for immune deficiency, infectious diseases and checkpoint resistant cancers by leveraging industry-leading, single-cell technologies. GigaGens novel technology platforms uniquely capture and recreate complete immune repertoires as functional antibody libraries. This approach has enabled the creation of first-in-class recombinant polyclonal antibody therapies for the treatment of infectious diseases. GigaGens lead oncology asset, GIGA-564, is an anti-CTLA-4 monoclonal antibody that has demonstrated improved anti-tumor efficacy in vivo through a unique mechanism of action. GigaGen is leveraging its proprietary technology platforms for the continued discovery of novel recombinant polyclonal drugs and monoclonal antibodies to treat life-threatening diseases.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access